Gastrointestinal Cancer Surgery

Dear Colleagues,

These are exciting times for surgeons, interventional and medical oncologists, pathologists and all other specialties involved in treating cancer patients. While personalized medicine is revolutionizing therapeutic strategies for gastrointestinal, hepatobiliary and pancreatic malignancies, precision surgery including robotics, augmented reality and artificial intelligence will, within this decade, drastically change the way we approach abdominal cancers.

We invite you to participate in this Special Issue of Cancers focusing on gastrointestinal cancer surgery and related fields, which aims to include all aspects related to colorectal, stomach and small bowel malignancies, as well as pancreatic, liver and biliary tract cancer. Contributions exploring the latest advancements in our understanding of the pathogenesis, diagnosis, treatment, and prevention of these malignancies are particularly encouraged. Potential topics may include, for example, the following:

• Surgical techniques, perioperative strategies, outcomes and complication management of gastrointestinal and HPB cancers;
• Pathology and molecular biology of gastrointestinal, hepatobiliary and pancreatic malignancies;
• Conventional, minimally invasive and interventional local treatment approaches;
• Personalized medicine and precision surgery;
• Robotics, augmented reality, artificial intelligence and big data in surgical oncology.

We look forward to your valuable contributions!

Dr. Florian Primavesi
Dr. Daniel Neureiter
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.